Volume 1 Number 1
Editorial
The history of EuroPCR... and why a new journal?
EuroInterv.2005;1:4-5
Next generation of drug eluting stents 'Sirolimus-analogues'
EuroInterv.2005;1:13-15
The future of cardiac surgery
EuroInterv.2005;1:17-19
Drug-eluting stents: the equalizers in treatment of bifurcational lesions
EuroInterv.2005;1:21-23
Clinical research
1
Treatment of de novo bifurcation lesions: comparison of Sirolimus- and Paclitaxel-eluting stentsEuroInterv.2005;1:24-30
2
Influence of technical strategies on the outcome of coronary bifurcation stentingEuroInterv.2005;1:31-37
3
Relation between the A1166C angiotensin II type 1 receptor gene polymorphism and cardiovascular outcomes after myocardial infarctionEuroInterv.2005;1:38-42
4
Primary transcatheter closure of postinfarction ventricular septal defects with the Amplatzer septal occluder - immediate results and up-to 5 years follow-upEuroInterv.2005;1:43-47
5
Percutaneous closure of patent foramen ovale: head-to-head comparison of two different devicesEuroInterv.2005;1:48-52
6
Six-month results of a randomized study to evaluate safety and efficacy of a Biolimus A9™ eluting stent with a biodegradable polymer coatingEuroInterv.2005;1:53-57
7
A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trialEuroInterv.2005;1:58-65
8
In-laboratory femoral sheath removal after heparin reversal by protamine after percutaneous coronary interventionEuroInterv.2005;1:66-69
9
Safety and feasibility of Bivalirudin with either Cypher and Taxus drug-eluting stent during percutaneous coronary interventionEuroInterv.2005;1:70-74
10
Critical limb ischemia: a global epidemic.A critical analysis of current treatment unmasks the clinical and economic costs of CLI
EuroInterv.2005;1:75-84
11
Usefulness and clinical impact of a fractional flow reserve-targeted strategy for coronary artery stenting: FROST III, a multicenter prospective registryEuroInterv.2005;1:85-92
12
Microcoil embolization for ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathyEuroInterv.2005;1:93-97
13
Long-term clinical outcome after percutaneous transluminal coronary angioplasty with provisional stentingEuroInterv.2005;1:98-104
New devices



